Related Experiment Video
Updated: Jul 1, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany
Norbert Gattermann1, Wolf-Karsten Hofmann, Axel Meessen
1Universitätsklinikum Düsseldorf, Germany.
Abstract:
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases mainly affecting older people. The use of an increasing number of therapeutic options depends on a systematic risk stratification of the patients. A high percentage of MDS patients need blood transfusions as supportive care, which influence quality of life and cause a great part of the costs generated by MDS therapy. In this article which is based on a workshop about the burden of MDS held in October 2006 in Munich, MDS is discussed with regard to different aspects: current therapies, transfusion medicine, geriatrics, quality of life, and health economic aspects.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Therapeutic Drug Monitoring: Affecting Factors
Mitral Stenosis III: Medical Management
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

